{"entity":{"id":"nct06792734","kind":"trial","name":"Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas","aka":[],"tldr":"A phase 1 trial of BTM-3566 run by Bantam Pharmaceuticals, now recruiting.","summary":"Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas is a phase 1 interventional study registered as NCT06792734 by Bantam Pharmaceuticals, with 24 participants planned, started 2025-02-14. Conditions recorded: Lymphoma, B-Cell. Interventions recorded: BTM-3566.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06792734","url":"https://clinicaltrials.gov/study/NCT06792734"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma"],"sections":[],"technologies":[],"targets":[],"drugs":["btm-3566"],"companies":["bantam-pharmaceutical"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06792734","phase":"1","setting":"Phase 1A/1B Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas","sponsor":"Bantam Pharmaceuticals","enrolled":24,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06792734/","neighbours":{"cancer":[{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"btm-3566","kind":"drug","name":"BTM-3566","route":"/drugs/btm-3566/"}],"company":[{"id":"bantam-pharmaceutical","kind":"company","name":"Bantam Pharmaceutical","route":"/companies/bantam-pharmaceutical/"}]}}